ATRA
Price
$9.35
Change
+$0.77 (+8.97%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
55.26M
CRNX
Price
$29.37
Change
+$0.31 (+1.07%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
2.75B
30 days until earnings call
Interact to see
Advertisement

ATRA vs CRNX

Header iconATRA vs CRNX Comparison
Open Charts ATRA vs CRNXBanner chart's image
Atara Biotherapeutics
Price$9.35
Change+$0.77 (+8.97%)
Volume$298
Capitalization55.26M
Crinetics Pharmaceuticals
Price$29.37
Change+$0.31 (+1.07%)
Volume$16K
Capitalization2.75B
ATRA vs CRNX Comparison Chart in %
Loading...
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRA vs. CRNX commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRA is a Hold and CRNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (ATRA: $9.27 vs. CRNX: $29.37)
Brand notoriety: ATRA and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATRA: 74% vs. CRNX: 72%
Market capitalization -- ATRA: $55.26M vs. CRNX: $2.75B
ATRA [@Biotechnology] is valued at $55.26M. CRNX’s [@Biotechnology] market capitalization is $2.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRA’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • ATRA’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ATRA and CRNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRA’s TA Score shows that 3 TA indicator(s) are bullish while CRNX’s TA Score has 4 bullish TA indicator(s).

  • ATRA’s TA Score: 3 bullish, 5 bearish.
  • CRNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ATRA and CRNX are a bad buy in the short-term.

Price Growth

ATRA (@Biotechnology) experienced а +18.85% price change this week, while CRNX (@Biotechnology) price change was +3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

ATRA is expected to report earnings on May 15, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.75B) has a higher market cap than ATRA($55.3M). ATRA YTD gains are higher at: -30.353 vs. CRNX (-42.558). ATRA has higher annual earnings (EBITDA): -5.74M vs. CRNX (-373.49M). CRNX has more cash in the bank: 1.27B vs. ATRA (13.8M). ATRA has less debt than CRNX: ATRA (40.6M) vs CRNX (50.8M). ATRA has higher revenues than CRNX: ATRA (200M) vs CRNX (760K).
ATRACRNXATRA / CRNX
Capitalization55.3M2.75B2%
EBITDA-5.74M-373.49M2%
Gain YTD-30.353-42.55871%
P/E RatioN/AN/A-
Revenue200M760K26,316%
Total Cash13.8M1.27B1%
Total Debt40.6M50.8M80%
FUNDAMENTALS RATINGS
ATRA vs CRNX: Fundamental Ratings
ATRA
CRNX
OUTLOOK RATING
1..100
6453
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10070
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
5264
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ATRA's Valuation (74) in the Biotechnology industry is in the same range as CRNX (91) in the Pharmaceuticals Major industry. This means that ATRA’s stock grew similarly to CRNX’s over the last 12 months.

CRNX's Profit vs Risk Rating (70) in the Pharmaceuticals Major industry is in the same range as ATRA (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to ATRA’s over the last 12 months.

CRNX's SMR Rating (94) in the Pharmaceuticals Major industry is in the same range as ATRA (100) in the Biotechnology industry. This means that CRNX’s stock grew similarly to ATRA’s over the last 12 months.

ATRA's Price Growth Rating (52) in the Biotechnology industry is in the same range as CRNX (64) in the Pharmaceuticals Major industry. This means that ATRA’s stock grew similarly to CRNX’s over the last 12 months.

ATRA's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CRNX (100) in the Pharmaceuticals Major industry. This means that ATRA’s stock grew similarly to CRNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRACRNX
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
87%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ATRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USBLX28.33N/A
N/A
Victory Growth and Tax Strategy
FIGSX19.80N/A
N/A
Fidelity Series International Growth
CSRYX38.81N/A
N/A
Columbia Select Large Cap Value Inst3
STRLX59.60N/A
N/A
Sterling Capital MdCp Relatv Val A
FSCWX32.91N/A
N/A
Nuveen Small Cap Value R6

ATRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRA has been closely correlated with IKNA. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if ATRA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRA
1D Price
Change %
ATRA100%
+8.04%
IKNA - ATRA
72%
Closely correlated
+1.48%
ABCZF - ATRA
53%
Loosely correlated
N/A
RAPT - ATRA
37%
Loosely correlated
-1.59%
PHAT - ATRA
36%
Loosely correlated
+4.16%
LENZ - ATRA
33%
Loosely correlated
-0.38%
More

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+1.07%
XNCR - CRNX
59%
Loosely correlated
+4.16%
TRDA - CRNX
57%
Loosely correlated
+2.73%
IDYA - CRNX
55%
Loosely correlated
+1.37%
RVMD - CRNX
55%
Loosely correlated
-0.63%
DYN - CRNX
55%
Loosely correlated
+2.57%
More